Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2040-2051, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280635
2.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 393(10183): 1819-1830, 2019 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955977
3.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Lancet
; 389(10066): 255-265, 2017 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979383
4.
Two neoplasms rich in small lymphocytes, B1B2 thymoma and small lymphocytic lymphoma, intermingled in one tumor mass. A case report.
Pol J Pathol
; 68(1): 75-81, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28547984
5.
Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.
Tumour Biol
; 37(2): 2049-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341493
6.
Analysis of treatment results in primary germ cell tumours with mediastinal location: own experience.
Pneumonol Alergol Pol
; 82(2): 116-24, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615195
7.
[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations]. / Rola systemowych metod leczenia u chorych na niedrobnokomórkowego raka pluca i zlosliwego miedzybloniaka oplucnej: uaktualnione zalecenia ekspertów.
Pneumonol Alergol Pol
; 82(2): 133-49, 2014.
Artigo
em Polonês
| MEDLINE | ID: mdl-24615197
8.
Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.
Contemp Oncol (Pozn)
; 18(1): 7-16, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24876815
9.
Clinicopathological characteristics of patients with primary tracheal tumors: Analysis of eighty-nine cases.
Thorac Cancer
; 15(11): 878-883, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429910
10.
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial.
J Thorac Oncol
; 19(2): 297-313, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748693
11.
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.
Front Oncol
; 14: 1341084, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38322415
12.
Prognostic value of synaptophysin and chromogranin a expression in patients receiving palliative chemotherapy for advanced non-small-cell lung cancer.
Respiration
; 85(4): 289-96, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22472871
13.
Savolitinib for non-small cell lung cancer.
Drugs Today (Barc)
; 59(1): 17-36, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811415
14.
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer.
Curr Oncol
; 30(2): 2049-2060, 2023 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826120
15.
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice.
J Clin Med
; 12(6)2023 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36983409
16.
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.
Cancers (Basel)
; 15(4)2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831618
17.
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.
J Clin Oncol
; 41(11): 1986-1991, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306479
18.
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
J Clin Oncol
; 41(11): 1999-2006, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735893
19.
Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC.
J Thorac Oncol
; 18(11): 1568-1580, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295609
20.
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON.
Cancer Discov
; 13(1): 98-113, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264123